IE900245L - Transdermal drug delivery composition - Google Patents

Transdermal drug delivery composition

Info

Publication number
IE900245L
IE900245L IE900245A IE24590A IE900245L IE 900245 L IE900245 L IE 900245L IE 900245 A IE900245 A IE 900245A IE 24590 A IE24590 A IE 24590A IE 900245 L IE900245 L IE 900245L
Authority
IE
Ireland
Prior art keywords
drug delivery
transdermal drug
delivery composition
compositions
oral
Prior art date
Application number
IE900245A
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IE900245L publication Critical patent/IE900245L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/553—Renin inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions having enhanced membrane permeability that comprise a therapeutically active ingredient, a penetration enhancer, a solubilizing agent and a solvent vehicle. These compositions are useful in oral and transdermal applications. [WO9008553A1]
IE900245A 1989-01-24 1990-01-22 Transdermal drug delivery composition IE900245L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30131089A 1989-01-24 1989-01-24

Publications (1)

Publication Number Publication Date
IE900245L true IE900245L (en) 1990-07-24

Family

ID=23162825

Family Applications (1)

Application Number Title Priority Date Filing Date
IE900245A IE900245L (en) 1989-01-24 1990-01-22 Transdermal drug delivery composition

Country Status (6)

Country Link
KR (1) KR910700066A (en)
AU (1) AU5041190A (en)
GR (1) GR900100044A (en)
IE (1) IE900245L (en)
IL (1) IL93143A0 (en)
WO (1) WO1990008553A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN101875608B (en) * 2010-05-31 2014-01-22 沈阳药科大学 Carveol ester derivative and percutaneous absorption preparation containing same
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7800762A (en) * 1978-01-20 1979-07-24 Acf Chemiefarma Nv LIQUID INJECTION PHARMACEUTICAL COMPOSITIONS.
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
EP0127426A1 (en) * 1983-05-23 1984-12-05 Takeda Chemical Industries, Ltd. Percutaneous pharmaceutical compositions for external use
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
JPS60149530A (en) * 1984-01-13 1985-08-07 Takeda Chem Ind Ltd Pharmaceutical water-based preparation
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions

Also Published As

Publication number Publication date
KR910700066A (en) 1991-03-13
IL93143A0 (en) 1990-11-05
AU5041190A (en) 1990-08-24
WO1990008553A1 (en) 1990-08-09
GR900100044A (en) 1991-06-07

Similar Documents

Publication Publication Date Title
IE890921L (en) Pharmaceutical composition for systemic transdermal administration
SE9301171D0 (en) PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC DRUGS
EP0279977A3 (en) Transdermal administration of progesterone, estradiol esters and mixtures thereof
IE871584L (en) Sustained release capsule.
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
WO1995001167A3 (en) Incorporating poly-n-vinyl amide in a transdermal system
ZA962536B (en) Pharmaceutical composition for transdermal administration.
CA2004598A1 (en) Medicinal aerosol formulations
BG106030A (en) Pharmaceutical composition
CA2259532A1 (en) Transdermal drug delivery matrix for coadministering estradiol and another steroid
IE900580L (en) Therapeutic system for the retarded and controlled¹transdermal or transmucous administration of active¹substances (ii)
WO1996040086A3 (en) Compositions and methods for topical administration of pharmaceutically active agents
CA2172616A1 (en) Tropyl 7-azaindol-3-ylcarboxyamides as antitussive agent
CA2309159A1 (en) Skin penetration enhancing components
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
CA2189328A1 (en) Tocopherol compositions for delivery of biologically active agents
CA2058428A1 (en) Analgesic formulations
CA2252772A1 (en) Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
IE852593L (en) Compositions containing anthracycline glycosides
CA2311450A1 (en) Pharmaceutical aerosol compositions
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
EP0165696A3 (en) Improved transdermal dosage form
WO2001041742A3 (en) Antiviral medication
EP0315219A3 (en) Pharmaceutical compositions